Company Profile

Amarin Corporation Stock Price, News & Analysis

Ticker:
AMRN
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Amarin is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

15.97 USD (+1.01%)

Close

Last updated: June 23, 2026 at 00:00

334.88M USD

Market cap

Why the stock is moving

AMRN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Amarin is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Amarin is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Amarin follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Amarin sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Amarin Corporation (AMRN)?

    Amarin Corporation (AMRN) most recently closed at 15.97 USD, a +1.01% move versus the previous session.

    What is the market cap of Amarin Corporation (AMRN)?

    Amarin Corporation currently has a market capitalization of 334.88M USD on BioPharmSignal.

    What does Amarin Corporation do?

    Amarin is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    On which exchange is AMRN stock listed?

    Amarin Corporation (AMRN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Amarin is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

    What is Amarin?

    Amarin is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    Which conditions is Amarin Corporation targeting with Amarin?

    Amarin is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    What is Investors?

    Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.